Latest Health News
Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress
Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and…
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million…
Data at ADA 2026 Highlights Key Findings from Clinical and RealWorld Studies of MannKinds Afrezza (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems
Builds on recent FDA approval (May 29, 2026) of Afrezza for use…
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
Publication presented concurrently with oral presentation at American Diabetes Association’s 86th Scientific…
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
June 05, 2026 16:05 ET | Source: Shattuck Labs, Inc. AUSTIN, Texas…
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares
June 05, 2026 16:01 ET | Source: Jade Biosciences SAN FRANCISCO and…
Laguna Treatment Center Warns of Concerning Increase in Patients Seeking Help for Kratom Addiction
ALISO VIEJO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Laguna Treatment Center,…
Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service
June 04, 2026 18:11 ET | Source: Aja Health and Wellness Inc.…
Orange Plan Management Celebrates 4.9-Star Review Milestone, Reinforcing Its Role as a Leading NDIS Plan Manager in Australia
June 04, 2026 17:50 ET | Source: Orange Plan Management Brisbane, QUEENSLAND,…
